Erlotinib sók

• 收藏
• 分享

专利权人:

EGIS GYOGYSZERGYAR NYRT.

发明人:

DR. MARVANYOS EDE,DR. NEMETH GABOR,DR. VOLK BALAZS,DR. PONGO LASZLO,DR. BARKOCZY JOZSEF,DR. DANCSO ANDRAS,MEZOEVARI MONIKA,VARGA ZOLTAN

申请号：

HU1100562

公开号：

HU230483B1

申请日:

2011.10.10

申请国别(地区):

HU

年份:

2016

代理人:

摘要：

The invention relates to erlotinib salts selected from the group consisting of the maleic acid salt, salicylic acid salt. L-mandelic acid alt. adipinic acid salt. 1.5-naphthalene-disulfonic acid salt. L-pyroglutamic acid salt. 1 -hydroxy-2-naphthoic acid salt, and mandelic acid salt and amorphous and crystalline forms, hydrates and solvates thereof. The erlotinib salts of the present invention are useful in therapy, particularly for the treatment or prophylaxis of non- small cell lung carcinoma and pancreas rarcinoma.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/